0
Fizzi Posted 19 years ago
Letter Writing
Letter_invitation
0 01 font 01 font 01 font 01 font 02 br
02 br
00 Hi all, 02 br
00 Would somebody please help me with the English? 02 br
00 Regards, 02 br
02 br
00 Fizzi 02 br
02 br
00 Dear Dr 01 i 00 ______ _________ 02 i 00 , 02 br
02 br
00 I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). You were selected at random to participate in this survey. 02 br
02 br
00 Your participation in the survey is very important but it is strictly voluntary and you may withdraw from the research at anytime. The result of this study will be a part of the thesis to be submitted as a requirement for the degree of Doctor of Philosophy, University of X. 02 br
02 br
00 The purpose of this comparative study is to determine the quality of information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). This study is done with the aim to improve the quality of information provide by pharmaceutical industry to doctors. 02 br
02 br
00 If you accept to participate to this study, you will need to evaluate pharmaceutical information given in a presentation by pharmaceutical representative. Following each sales visit you have to fill out a questionnaire focusing only on the main product or claim discussed in the discussion. No attempt will be made to influence pharmaceutical representatives and doctors discussion. 02 br
02 br
00 As an attempt to evaluate the actual practice of pharmaceutical representatives, informed consent will not be obtained from them. You will need to advise them that their visit could be monitored for the purpose of a study on the quality of information provided to doctors. No data will be collected on identities of pharmaceutical representatives and doctors. 02 br
02 br
00 Pharmaceutical representatives will be informed by a leaflet of the details of the study such as does not include any recording (audio or videotape of the visits). They will not be told if their personal meeting will be monitored and will be assured that all identifying data on pharmaceutical representatives and doctors would be kept strictly confidential. 02 br
02 br
00 Another part of the research, you will need to collect all research articles and printed material (e.g. pamphlets, detailing card) for further investigation. 02 br
02 br
00 All information collected as part of the study will be retained for seven years. Information will be kept electronically and also in hand-written notes. All records containing personal information will remain confidential and no information which could lead to identification of any individual will be released. 02 br
02 br
00 Please do not hesitate to contact me if you need any further information. 02 br
02 br
00 Yours sincerely, 02 br
02 font 01 font 02 font 02 font 02 font 02 font 00 0-
02 br
00 Hi all, 02 br
00 Would somebody please help me with the English? 02 br
00 Regards, 02 br
02 br
00 Fizzi 02 br
02 br
00 Dear Dr 01 i 00 ______ _________ 02 i 00 , 02 br
02 br
00 I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). You were selected at random to participate in this survey. 02 br
02 br
00 Your participation in the survey is very important but it is strictly voluntary and you may withdraw from the research at anytime. The result of this study will be a part of the thesis to be submitted as a requirement for the degree of Doctor of Philosophy, University of X. 02 br
02 br
00 The purpose of this comparative study is to determine the quality of information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). This study is done with the aim to improve the quality of information provide by pharmaceutical industry to doctors. 02 br
02 br
00 If you accept to participate to this study, you will need to evaluate pharmaceutical information given in a presentation by pharmaceutical representative. Following each sales visit you have to fill out a questionnaire focusing only on the main product or claim discussed in the discussion. No attempt will be made to influence pharmaceutical representatives and doctors discussion. 02 br
02 br
00 As an attempt to evaluate the actual practice of pharmaceutical representatives, informed consent will not be obtained from them. You will need to advise them that their visit could be monitored for the purpose of a study on the quality of information provided to doctors. No data will be collected on identities of pharmaceutical representatives and doctors. 02 br
02 br
00 Pharmaceutical representatives will be informed by a leaflet of the details of the study such as does not include any recording (audio or videotape of the visits). They will not be told if their personal meeting will be monitored and will be assured that all identifying data on pharmaceutical representatives and doctors would be kept strictly confidential. 02 br
02 br
00 Another part of the research, you will need to collect all research articles and printed material (e.g. pamphlets, detailing card) for further investigation. 02 br
02 br
00 All information collected as part of the study will be retained for seven years. Information will be kept electronically and also in hand-written notes. All records containing personal information will remain confidential and no information which could lead to identification of any individual will be released. 02 br
02 br
00 Please do not hesitate to contact me if you need any further information. 02 br
02 br
00 Yours sincerely, 02 br
02 font 01 font 02 font 02 font 02 font 02 font 00 0-
Top answer
0 Dear Dr 01 i 00 ______ _________ 02 i 00 , 02 br 02 br 00 I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). 02 br 02 br 00 Your participation in the survey is very important but it is strictly voluntary and you may withdraw from the research at 01 b 00 any time 02 b 00 . 02 br 02 br 00 The purpose of this comparative study is to determine the quality of information provided by pharmaceutical representatives to doctors in (country 1) and (country 2).
- 0 Dear Dr 01 i 00 ______ _________ 02 i 00 , 02 br 02 br 00 I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2).
- 02 br 02 br 00 Your participation in the survey is very important but it is strictly voluntary and you may withdraw from the research at 01 b 00 any time 02 b 00 .
- 02 br 02 br 00 The purpose of this comparative study is to determine the quality of information provided by pharmaceutical representatives to doctors in (country 1) and (country 2).
- 02 br 02 br 00 If you 01 b 00 agree 02 b 00 to participate 01 b 00 in 02 b 00 this study, you will need to evaluate pharmaceutical information given in presentation 01 b 00 s 02 b 00 by pharmaceutical representative 01 b 00 s 02 b 00 .
- Following each sales visit you 01 b 00 will 02 b 00 have to fill out a questionnaire focusing only on the main product or claim discussed.
Get the Weekly English Kit 📬
New words, one handy idiom, and a 2-minute quiz — delivered to your inbox to keep your streak alive.
2 Answers
0
0 Dear Dr 01 i 00 ______ _________ 02 i 00 , 02 br
02 br
00 I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). You were selected at random to participate in this survey. 02 br
02 br
00 Your participation in
02 br
00 I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). You were selected at random to participate in this survey. 02 br
02 br
00 Your participation in
00
0 You are right. I have overlooked the information on the duration for each evaluation. Thanks again. 02 br
02 br
00 Regards, 02 br
02 br
00 Fizzi 0-
02 br
00 Regards, 02 br
02 br
00 Fizzi 0-
0
Related Questions